Pfizer Inc.
PFE
Helyezés a részvények között
#111
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Részvényárfolyam
$30.05
Piaci kapitalizáció
$171.25B
Változás (1 nap)
-0.36%
Változás (1 év)
20.91%
Ország
US
Kereskedés Pfizer Inc. (PFE)
Kategória
Healthcare
Bevétel a(z) Pfizer Inc. (PFE) részvényhez
Bevétel ekkor: Jun 2026 TTM: $63.70B
Pfizer Inc. legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $63.70B. 2024 évben a vállalat $63.63B árbevételt ért el, amely növekedés a 2023 évben elért $59.55B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Pfizer Inc. bevételtörténete 2000 és 2026 között
Bevétel az év végén
| Év | Bevétel | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $63.70B | 1.78% |
| 2025 | $62.58B | -1.65% |
| 2024 | $63.63B | 6.84% |
| 2023 | $59.55B | -40.64% |
| 2022 | $100.33B | 23.43% |
| 2021 | $81.29B | 95.16% |
| 2020 | $41.65B | 1.16% |
| 2019 | $41.17B | -23.25% |
| 2018 | $53.65B | 2.10% |
| 2017 | $52.55B | -0.53% |
| 2016 | $52.82B | 8.13% |
| 2015 | $48.85B | -1.52% |
| 2014 | $49.61B | -3.84% |
| 2013 | $51.58B | -5.62% |
| 2012 | $54.66B | -10.45% |
| 2011 | $61.04B | -8.98% |
| 2010 | $67.06B | 34.09% |
| 2009 | $50.01B | 3.55% |
| 2008 | $48.30B | -0.27% |
| 2007 | $48.43B | 0.12% |
| 2006 | $48.37B | 2.04% |
| 2005 | $47.41B | -9.73% |
| 2004 | $52.52B | 16.22% |
| 2003 | $45.19B | 39.59% |
| 2002 | $32.37B | 0.35% |
| 2001 | $32.26B | 9.08% |
| 2000 | $29.57B | 0.00% |
Hasonló cégek vagy versenytársak bevétele
| Vállalat | Bevétel | Bevételkülönbség | Ország |
|---|---|---|---|
| $79.67B | 25.07% |
US
|
|
| $99.34B | 55.95% |
US
|
|
| $64.39B | 1.08% |
US
|
|
| $66.40B | 4.25% |
US
|
|
| $77.52B | 21.70% |
CH
|
